KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Notes Payables (2022 - 2025)

Opko Health's Notes Payables history spans 3 years, with the latest figure at $101.2 million for Q1 2025.

  • For Q1 2025, Notes Payables rose 59454.12% year-over-year to $101.2 million; the TTM value through Mar 2025 reached $101.2 million, up 59454.12%, while the annual FY2024 figure was $170000.0, N/A changed from the prior year.
  • Notes Payables reached $101.2 million in Q1 2025 per OPK's latest filing, up from $170000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $101.2 million in Q1 2025 to a low of $170000.0 in Q1 2024.
  • Average Notes Payables over 3 years is $25.1 million, with a median of $170000.0 recorded in 2024.
  • The largest YoY upside for Notes Payables was 59454.12% in 2025 against a maximum downside of 59454.12% in 2025.
  • A 3-year view of Notes Payables shows it stood at $3.0 million in 2022, then crashed by 94.43% to $170000.0 in 2024, then surged by 59454.12% to $101.2 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Notes Payables are $101.2 million (Q1 2025), $170000.0 (Q4 2024), and $170000.0 (Q3 2024).